Incannex Healthcare LimitedIXHLNASDAQ
Loading
Year-over-year research & development expense growth
Latest
0.00%
↓ 100% vs avg
Percentile
P21
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
49.52%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 0.00% |
| Q2 2025 | 104.33% |
| Q1 2025 | 99.97% |
| Q4 2024 | -46.45% |
| Q3 2024 | -34.64% |
| Q2 2024 | 29.32% |
| Q1 2024 | 30.54% |
| Q4 2023 | -5.09% |
| Q3 2023 | 68.95% |
| Q2 2023 | -1.19% |
| Q1 2023 | 7.62% |
| Q4 2022 | -88.16% |
| Q3 2022 | 1768.59% |
| Q2 2022 | -7.74% |
| Q1 2022 | 27.34% |
| Q4 2021 | 0.54% |
| Q3 2021 | -14.59% |
| Q2 2021 | -1.26% |
| Q1 2021 | 30.90% |
| Q4 2020 | 7.69% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q4 2019 | 3.96% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q4 2015 | 0.00% |
| Q3 2015 | 0.00% |